OBJECTIVE: To compare the prevalence estimates, comorbidity rates, and structural validity of a revised symptom criteria set for the diagnosis of posttraumatic stress disorder (PTSD) with those of the DSM-IV criteria in a representative community sample of adolescents. METHOD: Cross-sectional data from the National Survey of Adolescents, a 1995 household probability sample of 4,023 adolescents aged 12-17 years, were examined. DSM-IV PTSD symptoms were assessed with a modification of the National Women's Study PTSD module. Three- and 4-factor DSM-IV models were compared to a 2-factor PTSD model that deleted symptoms potentially overlapping with depression or other anxiety disorders. Comorbidity was assessed using DSM-IV criteria for major depressive episodes and substance use disorders. RESULTS: PTSD prevalence varied across models (ie, 5.2%-8.8%, lifetime; 3.2%-5.7%, past 6 months). When the 2-factor model was used with a proportionate symptom threshold, lifetime PTSD prevalence was comparable to that with the 3-factor DSM-IV model, and major depressive episode comorbidity was reduced by 9%-14%. Comorbidity with substance use disorders was comparable across models. Structural validity, tested with confirmatory factor analyses, showed that the 2-factor model and a 4-factor DSM-IV model were superior to the DSM-IV 3-factor model. CONCLUSION: Compared to the DSM-IV 3-factor PTSD model, a 2-factor model that removed depression and anxiety symptoms and used a proportionate symptom threshold may produce comparable lifetime PTSD prevalence estimates, reduced PTSD-depression comorbidity, and superior structural validity (comparable to a 4-factor PTSD model) when applied to community samples of adolescents. Further research on PTSD structure and diagnosis with adolescents is warranted. Copyright 2009 Physicians Postgraduate Press, Inc.
OBJECTIVE: To compare the prevalence estimates, comorbidity rates, and structural validity of a revised symptom criteria set for the diagnosis of posttraumatic stress disorder (PTSD) with those of the DSM-IV criteria in a representative community sample of adolescents. METHOD: Cross-sectional data from the National Survey of Adolescents, a 1995 household probability sample of 4,023 adolescents aged 12-17 years, were examined. DSM-IV PTSD symptoms were assessed with a modification of the National Women's Study PTSD module. Three- and 4-factor DSM-IV models were compared to a 2-factor PTSD model that deleted symptoms potentially overlapping with depression or other anxiety disorders. Comorbidity was assessed using DSM-IV criteria for major depressive episodes and substance use disorders. RESULTS:PTSD prevalence varied across models (ie, 5.2%-8.8%, lifetime; 3.2%-5.7%, past 6 months). When the 2-factor model was used with a proportionate symptom threshold, lifetime PTSD prevalence was comparable to that with the 3-factor DSM-IV model, and major depressive episode comorbidity was reduced by 9%-14%. Comorbidity with substance use disorders was comparable across models. Structural validity, tested with confirmatory factor analyses, showed that the 2-factor model and a 4-factor DSM-IV model were superior to the DSM-IV 3-factor model. CONCLUSION: Compared to the DSM-IV 3-factor PTSD model, a 2-factor model that removed depression and anxiety symptoms and used a proportionate symptom threshold may produce comparable lifetime PTSD prevalence estimates, reduced PTSD-depression comorbidity, and superior structural validity (comparable to a 4-factor PTSD model) when applied to community samples of adolescents. Further research on PTSD structure and diagnosis with adolescents is warranted. Copyright 2009 Physicians Postgraduate Press, Inc.
Authors: Arthur R Andrews; Lisa Jobe-Shields; Cristina M López; Isha W Metzger; Michael A R de Arellano; Ben Saunders; Dean G Kilpatrick Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2015-06-06 Impact factor: 4.328
Authors: Anke de Haan; Markus A Landolt; Eiko I Fried; Kristian Kleinke; Eva Alisic; Richard Bryant; Karen Salmon; Sue-Huei Chen; Shu-Tsen Liu; Tim Dalgleish; Anna McKinnon; Alice Alberici; Jade Claxton; Julia Diehle; Ramón Lindauer; Carlijn de Roos; Sarah L Halligan; Rachel Hiller; Christian H Kristensen; Beatriz O M Lobo; Nicole M Volkmann; Meghan Marsac; Lamia Barakat; Nancy Kassam-Adams; Reginald D V Nixon; Susan Hogan; Raija-Leena Punamäki; Esa Palosaari; Elizabeth Schilpzand; Rowena Conroy; Patrick Smith; William Yule; Richard Meiser-Stedman Journal: J Child Psychol Psychiatry Date: 2019-11-07 Impact factor: 8.982
Authors: Zachary W Adams; Jenna L McCauley; Sudie E Back; Julianne C Flanagan; Rochelle F Hanson; Therese K Killeen; Carla Kmett Danielson Journal: J Child Adolesc Subst Abuse Date: 2016-06-10
Authors: Lynsay A Ayer; Josh M Cisler; Carla Kmett Danielson; Ananda B Amstadter; Benjamin E Saunders; Dean G Kilpatrick Journal: J Anxiety Disord Date: 2010-11-12
Authors: T D Satterthwaite; P A Cook; S E Bruce; C Conway; E Mikkelsen; E Satchell; S N Vandekar; T Durbin; R T Shinohara; Y I Sheline Journal: Mol Psychiatry Date: 2015-09-29 Impact factor: 15.992